Home › Quadriplegia › New York › New York City
Quadriplegia clinical trials in New York City, NY
5 studies for Quadriplegia are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury
RecruitingHealthy volunteers welcome
- Columbia University Irving Medical Center, New York
Spinal Cord Associative Plasticity Study
RecruitingEarly phase 1Healthy volunteers welcome
- Bronx Veterans Medical Research Foundation, Inc, New York
- Columbia University Irving Medical Center, New York
- Weill Cornell Medicine, New York
Evaluation of Brain MRI Changes in Cerebral Palsy Patients
RecruitingObservational studyHealthy volunteers welcome
- Weinberg Family Cerebral Palsy Center, Columbia University, New York
Self-balancing Personal Exoskeleton for SCI (WINY)
RecruitingHealthy volunteers welcome
- Walk in New York (WINY) Physical Therapy, P.C., New York
Targeting Cervical Epidural Spinal Cord Stimulation for Functional Recovery
Recruiting
- Columbia University Irving Medical Center, New York
- The Daniel and Jane Och Spine Hospital at NewYork-Presbyterian/Allen, New York
Quadriplegia trials in other cities
- Cleveland, OH6 studies
- Baltimore, MD5 studies
- Boston, MA4 studies
- Mountain View, CA4 studies
- Sacramento, CA3 studies
- The Bronx, NY3 studies
- Newark, NJ3 studies
- Charleston, SC3 studies
- Downey, CA3 studies
- Miami, FL3 studies
- Houston, TX3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.